Direct detection of extended-spectrum beta-lactamases (CTX-M) from blood cultures by LC-MS/MS bottom-up proteomics

Rapid bacterial species identification and antibiotic susceptibility testing in positive blood cultures have an important impact on the antibiotic treatment for patients. To identify extended-spectrum beta-lactamases (ESBL) directly in positive blood culture bottles, we developed a workflow of sapon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical microbiology & infectious diseases 2017-09, Vol.36 (9), p.1621-1628
Hauptverfasser: Fleurbaaij, F., Goessens, W., van Leeuwen, H. C., Kraakman, M. E. M., Bernards, S. T., Hensbergen, P. J., Kuijper, E. J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1628
container_issue 9
container_start_page 1621
container_title European journal of clinical microbiology & infectious diseases
container_volume 36
creator Fleurbaaij, F.
Goessens, W.
van Leeuwen, H. C.
Kraakman, M. E. M.
Bernards, S. T.
Hensbergen, P. J.
Kuijper, E. J.
description Rapid bacterial species identification and antibiotic susceptibility testing in positive blood cultures have an important impact on the antibiotic treatment for patients. To identify extended-spectrum beta-lactamases (ESBL) directly in positive blood culture bottles, we developed a workflow of saponin extraction followed by a bottom-up proteomics approach using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The workflow was applied to positive blood cultures with Escherichia coli and Klebsiella pneumoniae collected prospectively in two academic hospitals over a 4-month period. Of 170 positive blood cultures, 22 (12.9%) contained ESBL-positive isolates based on standard susceptibility testing. Proteomic analysis identified CTX-M ESBLs in 95% of these isolates directly in positive blood cultures, whereas no false positives were found in the non-ESBL producing positive blood cultures. The results were confirmed by molecular characterisation of beta-lactamase genes. Based on this proof-of-concept study, we conclude that LC-MS/MS-based protein analysis can directly identify extended-spectrum beta lactamases in E. coli and K. pneumoniae positive blood cultures, and could be further developed for application in routine diagnostics.
doi_str_mv 10.1007/s10096-017-2975-y
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5554287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1886752015</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-1ccd793301eec08fdd345216cacfe4b5838aa25e91211a0abfe455eebfbd3adf3</originalsourceid><addsrcrecordid>eNp1kU1LHTEUhkOp1FvbH9BNCXRjF6n5mNxMNoJc-wX34kIL3YVMcsaOzEzGJCPef2_kWlHBTQ6c9zlvzuFF6BOj3xil6iiVVy8JZYpwrSTZvkELVglJKqHEW7SgWlREKy720fuUrmiZqZV6h_Z5LbRilC1QPO0iuIw95FK6MOLQYrjNMHrwJE2lGecBN5At6a3LdrAJEj5cXfwlm6-4jaGIfQgeu7nPcyxas8XrFdmcH23OcRNyDgOZJzzFkCEMnUsf0F5r-wQfH-oB-vPj-8XqF1mf_fy9OlkTVymaCXPOKy0EZQCO1q33opKcLZ11LVSNrEVtLZegGWfMUtuUrpQATdt4YX0rDtDxzneamwG8gzFH25spdoONWxNsZ54rY_fPXIYbI6WseK2KweGDQQzXM6Rshi456Hs7QpiTYXW9VJJTJgv65QV6FeY4lvMM01zpsriqCsV2lIshpQjt4zKMmvtEzS5RUxI194mabZn5_PSKx4n_ERaA74BUpPES4pOvX3W9A89erpM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1927952174</pqid></control><display><type>article</type><title>Direct detection of extended-spectrum beta-lactamases (CTX-M) from blood cultures by LC-MS/MS bottom-up proteomics</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Fleurbaaij, F. ; Goessens, W. ; van Leeuwen, H. C. ; Kraakman, M. E. M. ; Bernards, S. T. ; Hensbergen, P. J. ; Kuijper, E. J.</creator><creatorcontrib>Fleurbaaij, F. ; Goessens, W. ; van Leeuwen, H. C. ; Kraakman, M. E. M. ; Bernards, S. T. ; Hensbergen, P. J. ; Kuijper, E. J.</creatorcontrib><description>Rapid bacterial species identification and antibiotic susceptibility testing in positive blood cultures have an important impact on the antibiotic treatment for patients. To identify extended-spectrum beta-lactamases (ESBL) directly in positive blood culture bottles, we developed a workflow of saponin extraction followed by a bottom-up proteomics approach using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The workflow was applied to positive blood cultures with Escherichia coli and Klebsiella pneumoniae collected prospectively in two academic hospitals over a 4-month period. Of 170 positive blood cultures, 22 (12.9%) contained ESBL-positive isolates based on standard susceptibility testing. Proteomic analysis identified CTX-M ESBLs in 95% of these isolates directly in positive blood cultures, whereas no false positives were found in the non-ESBL producing positive blood cultures. The results were confirmed by molecular characterisation of beta-lactamase genes. Based on this proof-of-concept study, we conclude that LC-MS/MS-based protein analysis can directly identify extended-spectrum beta lactamases in E. coli and K. pneumoniae positive blood cultures, and could be further developed for application in routine diagnostics.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-017-2975-y</identifier><identifier>PMID: 28397101</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibiotics ; Bacteria ; beta-Lactamases - chemistry ; beta-Lactamases - genetics ; beta-Lactamases - metabolism ; Biomarkers ; Biomedical and Life Sciences ; Biomedicine ; Blood ; Blood Culture ; Chromatography, Liquid ; E coli ; Escherichia coli - drug effects ; Escherichia coli - genetics ; Escherichia coli Infections - diagnosis ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - microbiology ; Faith healing ; Humans ; Internal Medicine ; Klebsiella ; Klebsiella Infections - diagnosis ; Klebsiella Infections - drug therapy ; Klebsiella Infections - microbiology ; Klebsiella pneumoniae ; Klebsiella pneumoniae - drug effects ; Klebsiella pneumoniae - genetics ; Liquid chromatography ; Mass spectrometry ; Mass spectroscopy ; Medical Microbiology ; Microbial Sensitivity Tests ; Original ; Original Article ; Prayer ; Prospective Studies ; Proteomics ; Proteomics - methods ; Sequence Analysis, DNA ; Workflow</subject><ispartof>European journal of clinical microbiology &amp; infectious diseases, 2017-09, Vol.36 (9), p.1621-1628</ispartof><rights>The Author(s) 2017</rights><rights>European Journal of Clinical Microbiology &amp; Infectious Diseases is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-1ccd793301eec08fdd345216cacfe4b5838aa25e91211a0abfe455eebfbd3adf3</citedby><cites>FETCH-LOGICAL-c470t-1ccd793301eec08fdd345216cacfe4b5838aa25e91211a0abfe455eebfbd3adf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10096-017-2975-y$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10096-017-2975-y$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28397101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fleurbaaij, F.</creatorcontrib><creatorcontrib>Goessens, W.</creatorcontrib><creatorcontrib>van Leeuwen, H. C.</creatorcontrib><creatorcontrib>Kraakman, M. E. M.</creatorcontrib><creatorcontrib>Bernards, S. T.</creatorcontrib><creatorcontrib>Hensbergen, P. J.</creatorcontrib><creatorcontrib>Kuijper, E. J.</creatorcontrib><title>Direct detection of extended-spectrum beta-lactamases (CTX-M) from blood cultures by LC-MS/MS bottom-up proteomics</title><title>European journal of clinical microbiology &amp; infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>Rapid bacterial species identification and antibiotic susceptibility testing in positive blood cultures have an important impact on the antibiotic treatment for patients. To identify extended-spectrum beta-lactamases (ESBL) directly in positive blood culture bottles, we developed a workflow of saponin extraction followed by a bottom-up proteomics approach using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The workflow was applied to positive blood cultures with Escherichia coli and Klebsiella pneumoniae collected prospectively in two academic hospitals over a 4-month period. Of 170 positive blood cultures, 22 (12.9%) contained ESBL-positive isolates based on standard susceptibility testing. Proteomic analysis identified CTX-M ESBLs in 95% of these isolates directly in positive blood cultures, whereas no false positives were found in the non-ESBL producing positive blood cultures. The results were confirmed by molecular characterisation of beta-lactamase genes. Based on this proof-of-concept study, we conclude that LC-MS/MS-based protein analysis can directly identify extended-spectrum beta lactamases in E. coli and K. pneumoniae positive blood cultures, and could be further developed for application in routine diagnostics.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>beta-Lactamases - chemistry</subject><subject>beta-Lactamases - genetics</subject><subject>beta-Lactamases - metabolism</subject><subject>Biomarkers</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Blood</subject><subject>Blood Culture</subject><subject>Chromatography, Liquid</subject><subject>E coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli Infections - diagnosis</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Faith healing</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Klebsiella</subject><subject>Klebsiella Infections - diagnosis</subject><subject>Klebsiella Infections - drug therapy</subject><subject>Klebsiella Infections - microbiology</subject><subject>Klebsiella pneumoniae</subject><subject>Klebsiella pneumoniae - drug effects</subject><subject>Klebsiella pneumoniae - genetics</subject><subject>Liquid chromatography</subject><subject>Mass spectrometry</subject><subject>Mass spectroscopy</subject><subject>Medical Microbiology</subject><subject>Microbial Sensitivity Tests</subject><subject>Original</subject><subject>Original Article</subject><subject>Prayer</subject><subject>Prospective Studies</subject><subject>Proteomics</subject><subject>Proteomics - methods</subject><subject>Sequence Analysis, DNA</subject><subject>Workflow</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU1LHTEUhkOp1FvbH9BNCXRjF6n5mNxMNoJc-wX34kIL3YVMcsaOzEzGJCPef2_kWlHBTQ6c9zlvzuFF6BOj3xil6iiVVy8JZYpwrSTZvkELVglJKqHEW7SgWlREKy720fuUrmiZqZV6h_Z5LbRilC1QPO0iuIw95FK6MOLQYrjNMHrwJE2lGecBN5At6a3LdrAJEj5cXfwlm6-4jaGIfQgeu7nPcyxas8XrFdmcH23OcRNyDgOZJzzFkCEMnUsf0F5r-wQfH-oB-vPj-8XqF1mf_fy9OlkTVymaCXPOKy0EZQCO1q33opKcLZ11LVSNrEVtLZegGWfMUtuUrpQATdt4YX0rDtDxzneamwG8gzFH25spdoONWxNsZ54rY_fPXIYbI6WseK2KweGDQQzXM6Rshi456Hs7QpiTYXW9VJJTJgv65QV6FeY4lvMM01zpsriqCsV2lIshpQjt4zKMmvtEzS5RUxI194mabZn5_PSKx4n_ERaA74BUpPES4pOvX3W9A89erpM</recordid><startdate>20170901</startdate><enddate>20170901</enddate><creator>Fleurbaaij, F.</creator><creator>Goessens, W.</creator><creator>van Leeuwen, H. C.</creator><creator>Kraakman, M. E. M.</creator><creator>Bernards, S. T.</creator><creator>Hensbergen, P. J.</creator><creator>Kuijper, E. J.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170901</creationdate><title>Direct detection of extended-spectrum beta-lactamases (CTX-M) from blood cultures by LC-MS/MS bottom-up proteomics</title><author>Fleurbaaij, F. ; Goessens, W. ; van Leeuwen, H. C. ; Kraakman, M. E. M. ; Bernards, S. T. ; Hensbergen, P. J. ; Kuijper, E. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-1ccd793301eec08fdd345216cacfe4b5838aa25e91211a0abfe455eebfbd3adf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>beta-Lactamases - chemistry</topic><topic>beta-Lactamases - genetics</topic><topic>beta-Lactamases - metabolism</topic><topic>Biomarkers</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Blood</topic><topic>Blood Culture</topic><topic>Chromatography, Liquid</topic><topic>E coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli Infections - diagnosis</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Faith healing</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Klebsiella</topic><topic>Klebsiella Infections - diagnosis</topic><topic>Klebsiella Infections - drug therapy</topic><topic>Klebsiella Infections - microbiology</topic><topic>Klebsiella pneumoniae</topic><topic>Klebsiella pneumoniae - drug effects</topic><topic>Klebsiella pneumoniae - genetics</topic><topic>Liquid chromatography</topic><topic>Mass spectrometry</topic><topic>Mass spectroscopy</topic><topic>Medical Microbiology</topic><topic>Microbial Sensitivity Tests</topic><topic>Original</topic><topic>Original Article</topic><topic>Prayer</topic><topic>Prospective Studies</topic><topic>Proteomics</topic><topic>Proteomics - methods</topic><topic>Sequence Analysis, DNA</topic><topic>Workflow</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fleurbaaij, F.</creatorcontrib><creatorcontrib>Goessens, W.</creatorcontrib><creatorcontrib>van Leeuwen, H. C.</creatorcontrib><creatorcontrib>Kraakman, M. E. M.</creatorcontrib><creatorcontrib>Bernards, S. T.</creatorcontrib><creatorcontrib>Hensbergen, P. J.</creatorcontrib><creatorcontrib>Kuijper, E. J.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fleurbaaij, F.</au><au>Goessens, W.</au><au>van Leeuwen, H. C.</au><au>Kraakman, M. E. M.</au><au>Bernards, S. T.</au><au>Hensbergen, P. J.</au><au>Kuijper, E. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct detection of extended-spectrum beta-lactamases (CTX-M) from blood cultures by LC-MS/MS bottom-up proteomics</atitle><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2017-09-01</date><risdate>2017</risdate><volume>36</volume><issue>9</issue><spage>1621</spage><epage>1628</epage><pages>1621-1628</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>Rapid bacterial species identification and antibiotic susceptibility testing in positive blood cultures have an important impact on the antibiotic treatment for patients. To identify extended-spectrum beta-lactamases (ESBL) directly in positive blood culture bottles, we developed a workflow of saponin extraction followed by a bottom-up proteomics approach using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The workflow was applied to positive blood cultures with Escherichia coli and Klebsiella pneumoniae collected prospectively in two academic hospitals over a 4-month period. Of 170 positive blood cultures, 22 (12.9%) contained ESBL-positive isolates based on standard susceptibility testing. Proteomic analysis identified CTX-M ESBLs in 95% of these isolates directly in positive blood cultures, whereas no false positives were found in the non-ESBL producing positive blood cultures. The results were confirmed by molecular characterisation of beta-lactamase genes. Based on this proof-of-concept study, we conclude that LC-MS/MS-based protein analysis can directly identify extended-spectrum beta lactamases in E. coli and K. pneumoniae positive blood cultures, and could be further developed for application in routine diagnostics.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>28397101</pmid><doi>10.1007/s10096-017-2975-y</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0934-9723
ispartof European journal of clinical microbiology & infectious diseases, 2017-09, Vol.36 (9), p.1621-1628
issn 0934-9723
1435-4373
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5554287
source MEDLINE; SpringerLink Journals
subjects Anti-Bacterial Agents - pharmacology
Antibiotics
Bacteria
beta-Lactamases - chemistry
beta-Lactamases - genetics
beta-Lactamases - metabolism
Biomarkers
Biomedical and Life Sciences
Biomedicine
Blood
Blood Culture
Chromatography, Liquid
E coli
Escherichia coli - drug effects
Escherichia coli - genetics
Escherichia coli Infections - diagnosis
Escherichia coli Infections - drug therapy
Escherichia coli Infections - microbiology
Faith healing
Humans
Internal Medicine
Klebsiella
Klebsiella Infections - diagnosis
Klebsiella Infections - drug therapy
Klebsiella Infections - microbiology
Klebsiella pneumoniae
Klebsiella pneumoniae - drug effects
Klebsiella pneumoniae - genetics
Liquid chromatography
Mass spectrometry
Mass spectroscopy
Medical Microbiology
Microbial Sensitivity Tests
Original
Original Article
Prayer
Prospective Studies
Proteomics
Proteomics - methods
Sequence Analysis, DNA
Workflow
title Direct detection of extended-spectrum beta-lactamases (CTX-M) from blood cultures by LC-MS/MS bottom-up proteomics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A00%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20detection%20of%20extended-spectrum%20beta-lactamases%20(CTX-M)%20from%20blood%20cultures%20by%20LC-MS/MS%20bottom-up%20proteomics&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Fleurbaaij,%20F.&rft.date=2017-09-01&rft.volume=36&rft.issue=9&rft.spage=1621&rft.epage=1628&rft.pages=1621-1628&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-017-2975-y&rft_dat=%3Cproquest_pubme%3E1886752015%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1927952174&rft_id=info:pmid/28397101&rfr_iscdi=true